Uwell Biopharma, Inc. (TPEX:7902)
Taiwan · Delayed Price · Currency is TWD 41.00
-0.60 (-1.44%)
At close: May 8, 2026
Uwell Biopharma Market Cap
Uwell Biopharma has a market cap or net worth of 8.2 billion as of May 8, 2026.
Market Cap
8.20B
Enterprise Value
7.88B
Revenue
35.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
41.00
Market Cap Chart
Since January 22, 2026, Uwell Biopharma's market cap has increased from 5.52B to 8.20B, an increase of 48.55%. That is a compound annual growth rate of 290.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 8.20B | -1.44% |
| May 7, 2026 | 8.32B | -1.54% |
| May 6, 2026 | 8.45B | -0.94% |
| May 5, 2026 | 8.53B | -0.70% |
| May 4, 2026 | 8.59B | -8.52% |
| Apr 30, 2026 | 9.39B | 2.18% |
| Apr 29, 2026 | 9.19B | -1.71% |
| Apr 28, 2026 | 9.35B | -0.43% |
| Apr 27, 2026 | 9.39B | 2.18% |
| Apr 24, 2026 | 9.19B | 1.10% |
| Apr 23, 2026 | 9.09B | 2.02% |
| Apr 22, 2026 | 8.91B | -2.73% |
| Apr 21, 2026 | 9.16B | -2.24% |
| Apr 20, 2026 | 9.37B | 3.77% |
| Apr 17, 2026 | 9.03B | -5.25% |
| Apr 16, 2026 | 9.53B | 10.43% |
| Apr 15, 2026 | 8.63B | 10.64% |
| Apr 14, 2026 | 7.80B | 2.50% |
| Apr 13, 2026 | 7.61B | -2.81% |
| Apr 10, 2026 | 7.83B | - |
| Apr 9, 2026 | 7.83B | 0.38% |
| Apr 8, 2026 | 7.80B | 2.23% |
| Apr 7, 2026 | 7.63B | -1.55% |
| Apr 2, 2026 | 7.75B | -3.13% |
| Apr 1, 2026 | 8.00B | 2.96% |
| Mar 31, 2026 | 7.77B | -2.75% |
| Mar 30, 2026 | 7.99B | -0.37% |
| Mar 27, 2026 | 8.02B | 0.75% |
| Mar 26, 2026 | 7.96B | -0.87% |
| Mar 25, 2026 | 8.03B | -2.07% |
| Mar 24, 2026 | 8.20B | 2.12% |
| Mar 23, 2026 | 8.03B | 2.82% |
| Mar 20, 2026 | 7.81B | -1.76% |
| Mar 19, 2026 | 7.95B | -0.63% |
| Mar 18, 2026 | 8.00B | -3.26% |
| Mar 17, 2026 | 8.27B | -2.59% |
| Mar 16, 2026 | 8.49B | 1.07% |
| Mar 13, 2026 | 8.40B | -3.00% |
| Mar 12, 2026 | 8.66B | -2.59% |
| Mar 11, 2026 | 8.89B | 1.02% |
| Mar 10, 2026 | 8.80B | -0.68% |
| Mar 9, 2026 | 8.86B | 0.45% |
| Mar 6, 2026 | 8.82B | 4.50% |
| Mar 5, 2026 | 8.44B | 7.52% |
| Mar 4, 2026 | 7.85B | -5.99% |
| Mar 3, 2026 | 8.35B | -6.70% |
| Mar 2, 2026 | 8.95B | -2.72% |
| Feb 26, 2026 | 9.20B | -7.91% |
| Feb 25, 2026 | 9.99B | -1.09% |
| Feb 24, 2026 | 10.10B | 15.96% |
| Feb 23, 2026 | 8.71B | 29.23% |
| Feb 11, 2026 | 6.74B | 0.60% |
| Feb 10, 2026 | 6.70B | 0.45% |
| Feb 9, 2026 | 6.67B | -0.74% |
| Feb 6, 2026 | 6.72B | -2.61% |
| Feb 5, 2026 | 6.90B | 2.37% |
| Feb 4, 2026 | 6.74B | 2.43% |
| Feb 3, 2026 | 6.58B | 5.11% |
| Feb 2, 2026 | 6.26B | 12.79% |
| Jan 30, 2026 | 5.55B | 2.78% |
| Jan 29, 2026 | 5.40B | 1.89% |
| Jan 28, 2026 | 5.30B | -3.46% |
| Jan 27, 2026 | 5.49B | 9.15% |
| Jan 26, 2026 | 5.03B | -0.79% |
| Jan 23, 2026 | 5.07B | -8.15% |
| Jan 22, 2026 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 18.01B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.44B |
| Intelligene | 7.51B |
| Obigen Pharma | 4.16B |
| BIONET Therapeutics | 2.84B |
| Pet Pharm Biotech | 2.73B |
| FullHope Biomedical | 1.13B |
| Han.biomedical | 683.57M |